These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16759105)

  • 1. Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.
    Vig BS; Stouch TR; Timoszyk JK; Quan Y; Wall DA; Smith RL; Faria TN
    J Med Chem; 2006 Jun; 49(12):3636-44. PubMed ID: 16759105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, short-circuit current, and intracellular pH.
    Chen M; Singh A; Xiao F; Dringenberg U; Wang J; Engelhardt R; Yeruva S; Rubio-Aliaga I; Nässl AM; Kottra G; Daniel H; Seidler U
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G265-74. PubMed ID: 20430876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells.
    Abe H; Satoh M; Miyauchi S; Shuto S; Matsuda A; Kamo N
    Bioconjug Chem; 1999; 10(1):24-31. PubMed ID: 9893960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of cyclic dipeptide by PEPT1 in Caco-2 cells: phenolic hydroxyl group of substrate enhances affinity for PEPT1.
    Mizuma T; Narasaka T; Awazu S
    J Pharm Pharmacol; 2002 Sep; 54(9):1293-6. PubMed ID: 12356285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
    Anand BS; Patel J; Mitra AK
    J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.
    Gebauer S; Knütter I; Hartrodt B; Brandsch M; Neubert K; Thondorf I
    J Med Chem; 2003 Dec; 46(26):5725-34. PubMed ID: 14667225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake, transport and regulation of JBP485 by PEPT1 in vitro and in vivo.
    Liu Z; Wang C; Liu Q; Meng Q; Cang J; Mei L; Kaku T; Liu K
    Peptides; 2011 Apr; 32(4):747-54. PubMed ID: 21262302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights into PEPT1-mediated transport of a novel antiepileptic, NP-647.
    Khomane KS; Nandekar PP; Wahlang B; Bagul P; Shaikh N; Pawar YB; Meena CL; Sangamwar AT; Jain R; Tikoo K; Bansal AK
    Mol Pharm; 2012 Sep; 9(9):2458-68. PubMed ID: 22779445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.
    Knütter I; Wollesky C; Kottra G; Hahn MG; Fischer W; Zebisch K; Neubert RH; Daniel H; Brandsch M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):432-41. PubMed ID: 18713951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
    Biegel A; Gebauer S; Hartrodt B; Brandsch M; Neubert K; Thondorf I
    J Med Chem; 2005 Jun; 48(13):4410-9. PubMed ID: 15974593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and functional characterization of the mammalian intestinal peptide transporter PepT1 in the methylotropic yeast Pichia pastoris.
    Döring F; Theis S; Daniel H
    Biochem Biophys Res Commun; 1997 Mar; 232(3):656-62. PubMed ID: 9126331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEPT1 involved in the uptake and transepithelial transport of cefditoren in vivo and in vitro.
    Zhang Q; Liu Q; Wu J; Wang C; Peng J; Ma X; Liu K
    Eur J Pharmacol; 2009 Jun; 612(1-3):9-14. PubMed ID: 19371738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080.
    Nakanishi T; Tamai I; Sai Y; Sasaki T; Tsuji A
    Cancer Res; 1997 Sep; 57(18):4118-22. PubMed ID: 9307302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of leptin on H+-coupled peptide cotransporter 1 activity and expression in vivo: evidence in leptin-deficient mice.
    Hindlet P; Bado A; Farinotti R; Buyse M
    J Pharmacol Exp Ther; 2007 Oct; 323(1):192-201. PubMed ID: 17622573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of oligopeptide transporter suppress growth of human pancreatic cancer cells.
    Mitsuoka K; Kato Y; Miyoshi S; Murakami Y; Hiraiwa M; Kubo Y; Nishimura S; Tsuji A
    Eur J Pharm Sci; 2010 Jun; 40(3):202-8. PubMed ID: 20307658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: synthesis and biological investigations.
    Våbenø J; Lejon T; Nielsen CU; Steffansen B; Chen W; Ouyang H; Borchardt RT; Luthman K
    J Med Chem; 2004 Feb; 47(4):1060-9. PubMed ID: 14761208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEPT1-mediated uptake of dipeptides enhances the intestinal absorption of amino acids via transport system b(0,+).
    Wenzel U; Meissner B; Döring F; Daniel H
    J Cell Physiol; 2001 Feb; 186(2):251-9. PubMed ID: 11169462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.
    Terada T; Sawada K; Irie M; Saito H; Hashimoto Y; Inui K
    Pflugers Arch; 2000 Sep; 440(5):679-84. PubMed ID: 11007306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of ethanol's toxic metabolite acetaldehyde on the gastrointestinal oligopeptide transporter, PEPT1: in vitro and in vivo studies.
    Fisher SJ; Lee IJ; Swaan PW; Eddington ND
    Alcohol Clin Exp Res; 2008 Jan; 32(1):162-70. PubMed ID: 18028524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration-dependent preferences of absorptive and excretive transport cause atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds.
    Mizuma T; Narasaka T; Hiyoshi W; Awazu S
    Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):199-209. PubMed ID: 15244036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.